GGrantIndex
← Leaderboards

Aaron J Johnson

University Of Cincinnati

$10,228,190
Attributed
$10,228,190
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.3M · FY200925
$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,228,190 · 7

By mechanism

R01$6,957,626 · 3
RF1$1,994,986 · 1
R21$878,078 · 2
R56$397,500 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Cincinnati

Same institution · by research overlap

Others in their field

Top investigators on “Innovation

Research focus

InnovationCell TypeCellsMouse ModelInflammationImmuneTransgenic MiceNervous System DisorderBrainVascular PermeabilitiesIn VivoPerforinMediatingBiological ModelsMagnetic Resonance ImagingAlzheimer&AposInflammatoryT Cell ResponseResponseProgramsCd8b1 GeneC57bl/6 MouseCerebral MalariaCd8-Positive T-Lymphocytes

Grant awards (26)

CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions$590,800
R01 · FY2025 · NS · contact PI
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy$587,768
R01 · FY2025 · NS · contact PI
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy$653,076
R01 · FY2024 · NS · contact PI
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions$399,756
R01 · FY2024 · NS · contact PI
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions$412,120
R01 · FY2023 · NS · contact PI
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement$61,330
RF1 · FY2023 · NS · contact PI
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions$412,120
R01 · FY2022 · NS · contact PI
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy$1,933,656
RF1 · FY2021 · NS · contact PI
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions$412,120
R01 · FY2021 · NS · contact PI
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions$412,120
R01 · FY2020 · NS · contact PI
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions$347,813
R01 · FY2019 · NS · contact PI
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions$347,813
R01 · FY2019 · NS · contact PI
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions$347,813
R01 · FY2018 · NS · contact PI
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions$347,813
R01 · FY2017 · NS · contact PI
Immune Contribution to Brain Atrophy$198,750
R21 · FY2017 · NS · contact PI
Immune Contribution to Brain Atrophy$60,420
R21 · FY2017 · NS · contact PI
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions$397,500
R56 · FY2016 · NS · contact PI
Immune Contribution to Brain Atrophy$238,500
R21 · FY2016 · NS · contact PI
Enhancing Glioma-Specific Immunity$207,495
R21 · FY2015 · CA · contact PI
Enhancing Glioma-Specific Immunity$172,913
R21 · FY2014 · CA · contact PI
CD 8 T Cell Mediated Disruption of Blood Brain Tight Junction$324,518
R01 · FY2013 · NS · contact PI
CD 8 T Cell Mediated Disruption of Blood Brain Tight Junction$336,968
R01 · FY2012 · NS · contact PI
CD 8 T Cell Mediated Disruption of Blood Brain Tight Junction$338,531
R01 · FY2011 · NS · contact PI
CD 8 T Cell Mediated Disruption of Blood Brain Tight Junction$334,358
R01 · FY2010 · NS · contact PI
CD 8 T Cell Mediated Disruption of Blood Brain Tight Junction$1
R01 · FY2010 · NS · contact PI
CD 8 T Cell Mediated Disruption of Blood Brain Tight Junction$352,118
R01 · FY2009 · NS · contact PI